Scholarlink

<p>Establishing well-described mouse models of hereditary diseases is increasingly important for testing new therapeutic approaches, such as gene replacement therapy. In particular, a detailed description of muscle pathology, especially at early timepoints of the disease, is crucial for determining the optimal timepoint for drug delivery and evaluation of therapeutic success. In this study, we aimed to characterize and quantify the muscle pathology and myofibre morphology of different muscles in a new mouse model for calpainopathy as an example of the heterogenous group of limb girdle muscular dystrophies compared to wildtype controls during the disease. We analysed motor function and muscle tissue of wildtype and <i>Capn3-</i>transgenic mice per gender from 1.5 to 15 months of age. While transgenic mice did not develop restrictions in motor function, tested with grip strength measurement, beam walk and four limb wire hanging test, during this period, gastrocnemius, soleus and psoas muscles showed progressive histopathological and ultrastructural changes. Importantly, we also detected gender-specific differences in general muscle structure and in muscle pathology in the mouse model of calpainopathy. We developed a score to classify pathology of muscles in this mouse model using percentage of myocytes with centralized nuclei to increase objectivity and comparability when using this mouse model.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Age, muscle, and gender specific characterization of muscle degeneration in a mouse model of calpainopathy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月12日

查看全文
  • Nicolina Südkamp,
  • Jacqueline Heinen-Weiler,
  • Marlena Rohm,
  • Michaela Zaik,
  • Nassam Daya,
  • Anne-Katrin Güttsches,
  • Carsten Theiss,
  • Andreas Roos,
  • Tobias Ruck,
  • Frank Jacobsen,
  • Lara Schlaffke,
  • Matthias Vorgerd

摘要

Establishing well-described mouse models of hereditary diseases is increasingly important for testing new therapeutic approaches, such as gene replacement therapy. In particular, a detailed description of muscle pathology, especially at early timepoints of the disease, is crucial for determining the optimal timepoint for drug delivery and evaluation of therapeutic success. In this study, we aimed to characterize and quantify the muscle pathology and myofibre morphology of different muscles in a new mouse model for calpainopathy as an example of the heterogenous group of limb girdle muscular dystrophies compared to wildtype controls during the disease. We analysed motor function and muscle tissue of wildtype and Capn3-transgenic mice per gender from 1.5 to 15 months of age. While transgenic mice did not develop restrictions in motor function, tested with grip strength measurement, beam walk and four limb wire hanging test, during this period, gastrocnemius, soleus and psoas muscles showed progressive histopathological and ultrastructural changes. Importantly, we also detected gender-specific differences in general muscle structure and in muscle pathology in the mouse model of calpainopathy. We developed a score to classify pathology of muscles in this mouse model using percentage of myocytes with centralized nuclei to increase objectivity and comparability when using this mouse model.